Frontlight ResearchEarly access
Trial site
Thessaloniki
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Coronary artery disease3 trials
- Familial hypercholesterolaemia3 trials
- Stroke3 trials
- Aortic stenosis1 trial
- Chronic myeloid leukaemia1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Pulmonary arterial hypertension1 trial
- Sickle cell disease1 trial
- Phase
- Phase 310 trials
- Phase 1/21 trial
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Completed3 trials
- Lead sponsor
- Novartis Pharmaceuticals12 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- Aortic stenosis1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026